The 6th International

Conference on Advances in

Hematology & Oncology August 4-5, 2018

The Coeur d’Alene Resort - Coeur d’Alene, ID

http://oncology.binayfoundation.org/

TARGET AUDIENCE Hematologists/OncologistsRadiation OncologistsSurgical OncologistsPrimary Care ProvidersPhysician AssistantsResidents & FellowsNurses/Nurse PractitionersPharmacistsResearchersOther Healthcare Providers

OBJECTIVES

At the conclusion of this activity, participants will be able to:

State common treatment options available to patients with hematologic malignancies & solid tumors,

Identify indications, contra-indications, and side effects of those available treatment options,

Apply the knowledge gained to provide appropriate counseling & care to patients receiving cancer treatment,

Describe the indications and contra-indications for immunotherapy treatment in cancer, and

Interpret and implement relevant date presented at the 2018 ASCO ¨ Annual Meeting

ASCO ¨ is a r egistered trademark of American Society of Clinical Oncology, Inc. All rights reserved worldwide.

All sessions will be video

recorded and made available

to the attendees of

ICAHO 2018 on the

conference website

ASCO®

ASCO®

WHY ATTEND ICAHO 2018?

2018 ASCO® Annual Meeting

review

Interact, ask questions, and network with

faculties & colleaguesall in one room

Renowned faculties Comprehensive topics

National level conference

Free wi-fi in the meeting hall

Venue your entire family will love!

This activity has been planned and implemented in accordance with the accreditation requirements

and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ada Canyon Medical

Education Consortium and the Binaytara Foundation. The Ada Canyon Medical Education Consortium

is accredited by the Idaho Medical Association and the Accreditation Council for Continuing Medical

Education to provide continuing medical education for physicians. The Ada Canyon

Medical Education Consortium designates this live activity for a maximum of 10.00 AMA PRA

Category 1 Credit(s)™. Physicians shouldclaim only the credit commensurate with

the extent of their participation in the activity.

ASCO ® is a registered trademark of American Society of Clinical Oncology, Inc. All rights reserved worldwide.

SUBMIT ABSTRACTS

Presented abstracts published in Anticancer Research Journal : 2016 Impact Factor 1.93

Travel grants for five top scoring abstractsAbstract Submission Deadline: June 15, 2018

Accepted categories include: Basic Science Research, Clinical Research

Case Reports, Health Outcome Research

Visit the conference website for more details: http://oncology.binayfoundation.org

email - hemeonc@binayfoundation.org

PROGRAM AGENDADAY 1 - Saturday, August 4, 2018

7:00 - 8:00 Registration/Breakfast

Lymphoid Malignancies Session

8:00 - 8:30 DLBCL: What’s New in 2018?8:30 - 9:00 Follicular Lymphoma9:00 - 9:30 CLL: Sequencing Current Therapies9:30 - 9:45 Q&A/Discussion

9:45 - 10:15 Break

Hematologic Malignancies Session

10:15 - 10:45 Updates in Multiple Myeloma10:45 - 11:15 Management of Acute Leukemia11:15 - 11:45 Approach to Management of MDS/MPN11:45 - 12:00 Q&A/Discussion

12:00 - 13:00 Lunch/Abstract Presentation

13:00 - 14:00 Global Oncology

Lung Cancer Session

14:00 -14:30 Management of Non-Small Cell Lung Cancer14:30 -15:00 How I Manage Lung Cancer15:00 -15:15 Q&A/Discussion

15:15 - 15:45 Break

Breast Cancer Session

15:45 - 16:15 Updates in Management of Breast Cancer16:15 - 16:45 Radiotherapy in Breast Cancer16:45 - 17:00 Q&A/Discussion

17:00 Day One Adjourn

Thanks to our partner

ICA

HO

201

8

PROGRAM AGENDADAY 2 - Sunday, August 5, 2018

7:00 - 8:00 Registration/Breakfast

GI Malignancies Session

8:00 - 8:30 Colon Cancer Management8:30 - 9:00 Upper GI Malignancies - ASCO® Updates9:00 - 9:15 Q&A/Discussion

9:15 - 9:45 Break

General Oncology Session

9:45 - 10:15 New Advances in Head & Neck Cancers10:15 - 10:45 Prostate Cancer: Optimizing the Use of Newer Agents10:45 - 11:15 Melanoma: Sequencing Therapies11:15 - 11:30 Q&A/Discussion

Medical Oncology Session Adjourns

11:30 - 13:00 Registration for Nursing Oncology Sessions

13:00 - 15:45 Nursing Oncology

Nursing Oncology Session I

13:00 -13:30 Cancer Survivorship & the Role of Nurses13:30 -14:00 The Spectrum of Palliative Care14:00 -14:15 Q&A/Discussion

14:15 - 14:30 Break

Nursing Oncology Session II

14:30 - 15:00 Oral Chemotherapy: Nurses’ Role in Compliance15:00 - 15:30 Managing Compassion Fatigue & Burnout15:30 - 15:45 Q&A/Discussion

15:45 Nursing Session AdjournICA

HO

201

8

FACULTY

Arvind Chaudhry, MD, PhDSummit Cancer Centers, Spokane

Brian Samuels, MDSummit Cancer Centers, Spokane

Evan Yu, MDUniversity of Washington, Seattle

John Pagel, MD, PhDSwedish Cancer Institute, Seattle

Kathryn Gold, MDUniversity of California, San Diego

Ranjana Advani, MDStanford University Medical Center, Stanford

Roland Walter, MD, PhD, MSUniversity of Washington, Seattle

Shaji Kumar, MDMayo Clinic School of Medicine, Rochester

V. K. Gadi, MD, PhDUniversity of Washington, Seattle

Axel Grothey, MDMayo Clinic School of Medicine, Rochester

Binay Shah, MD, MHABinaytara Foundation, Bellingham

Damiano Rondelli, MDUniversity of Illinois at Chicago

H. Jack West, MDSwedish Cancer Institute, Seattle

Kathleen Horst, MDStanford University Medical Center, Stanford

P. Venugopal, MDRush University Medical Center, Chicago

Renato Martins, MD, MPHUniversity of Washington, Seattle

Shailender Bhatia, MDUniversity of Washington, Seattle

Srinivas Tantravahi, MBBS, MRCPUniversity of Utah School of Medicine

Utkarsh Acharya, DO, FACPUniversity of Washington, Seattle

NURSING ONCOLOGY FACULTY

Derrel Walker, MDHorizon Home Health & Hospice, Meridian

Leslie Heron, RN, BSN, MN, ARNPSeattle Cancer Care Alliance, Seattle

Ferowsi Pocarero, PharmD, BCOPCHI Franciscan, Tacoma

Rennee Yankee, ARNPWhidbey General Hospital, Coupville

REGISTRATIONhttp://oncology.binayfoundation.org

Title Early ( by 6/30/18) Late (after 6/30/18)

Physicians $350.00 $400.00

Non-physician providers (RN/NP/PA/PharmD) $175.00 $225.00

Residents/fellows $175.00 $225.00

Researchers $175.00 $225.00

Nursing session only (8/5/18 - half day) $75.00 $100.00

Students $150.00 $200.00

Name

Affiliation

Professional Title

State City

Email

Cancellation policy: Registrations cancelled before June 30th, 2018 will receive a 50% refund. No refund will be issued if the registration is cancelled after that date. Please email hemeonc@binayfoundation.org to cancel registrations. We provide a donation receipt for the non-refundable portion of the registration fee.

Make Checks Payable to: Binaytara Foundation, 2219 Rimland Drive, Suite 301, Bellingham, WA 98226

A limited number of rooms have been reserved at the Coeur d’Alene Resort for the attendees of ICAHO18. All reservations should be made by June 23rd, 2018 to receive the discounted conference rate listed below. Call the Coeur d’Alene Resort group reservation staff at 866-582-6355 to book your hotel room, and to learn more about reservation policies and benefits. The group rate listed below doesn’t include taxes and fees. Attendees are advised to contact the Coeur d’Alene Resort for more information.

Lake Tower: $ 335/night

Park Tower: $ 275/night

North Wing: $ 225/night

ACCOMMODATIONS

The Binaytara Foundation (BTF) is a 501(c) 3 non-profit established in October of 2007 with the goal of bringing positive changes in people’s lives by promoting health and education.

Mission Statement

The Binaytara Foundation seeks to improve healthcare in resource-poor communities and improve access to cancer care worldwide by innovating cost-effective, culturally appropriate models of healthcare delivery; by advocating for better access and improved quality of care; and by educating healthcare providers and community members about various aspects of disease prevention and management.

ABOUT THE BINAYTARA FOUNDATION

70 4

We envision a world where every human

being will have access tohealthcare that is based

on evidence, thatis culturally appropriate,

and that improvestheir quality of life.